167 related articles for article (PubMed ID: 35440019)
21. Investigation of the Prognostic Role of Carbonic Anhydrase 9 (CAIX) of the Cellular mRNA/Protein Level or Soluble CAIX Protein in Patients with Oral Squamous Cell Carcinoma.
Eckert AW; Horter S; Bethmann D; Kotrba J; Kaune T; Rot S; Bache M; Bilkenroth U; Reich W; Greither T; Wickenhauser C; Vordermark D; Taubert H; Kappler M
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30654595
[TBL] [Abstract][Full Text] [Related]
22. Knockdown of OLA1, a regulator of oxidative stress response, inhibits motility and invasion of breast cancer cells.
Zhang JW; Rubio V; Zheng S; Shi ZZ
J Zhejiang Univ Sci B; 2009 Nov; 10(11):796-804. PubMed ID: 19882753
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of carbonic anhydrase IX as a potential therapeutic target in urothelial carcinoma.
Todenhöfer T; Gibb EA; Seiler R; Kamyabi A; Hennenlotter J; McDonald P; Moskalev I; Stewart C; Gao J; Fazli L; Dedhar S; Stenzl A; Oo HZ; Black PC
Urol Oncol; 2021 Aug; 39(8):498.e1-498.e11. PubMed ID: 34083096
[TBL] [Abstract][Full Text] [Related]
24. Regulation of HIF1α under Hypoxia by APE1/Ref-1 Impacts CA9 Expression: Dual Targeting in Patient-Derived 3D Pancreatic Cancer Models.
Logsdon DP; Grimard M; Luo M; Shahda S; Jiang Y; Tong Y; Yu Z; Zyromski N; Schipani E; Carta F; Supuran CT; Korc M; Ivan M; Kelley MR; Fishel ML
Mol Cancer Ther; 2016 Nov; 15(11):2722-2732. PubMed ID: 27535970
[TBL] [Abstract][Full Text] [Related]
25. OLA1, an Obg-like ATPase, suppresses antioxidant response via nontranscriptional mechanisms.
Zhang J; Rubio V; Lieberman MW; Shi ZZ
Proc Natl Acad Sci U S A; 2009 Sep; 106(36):15356-61. PubMed ID: 19706404
[TBL] [Abstract][Full Text] [Related]
26. TBX21 attenuates colorectal cancer progression via an ARHGAP29/RSK/GSK3β dependent manner.
Jiang X; Du W; Yang C; Wang S; Li Y; Shen X; Yang X; Yao J; Du R; Zhang X; Huang Y; Shen W
Cell Oncol (Dordr); 2023 Oct; 46(5):1269-1283. PubMed ID: 37067748
[TBL] [Abstract][Full Text] [Related]
27. Combined OLA1 and CLEC3B Gene Is a Prognostic Signature for Hepatocellular Carcinoma and Impact Tumor Progression.
Chen Z; Zeng L; Chen Z; Xu J; Zhang X; Ying H; Zeng Y; Yu F
Technol Cancer Res Treat; 2024; 23():15330338241241935. PubMed ID: 38564315
[TBL] [Abstract][Full Text] [Related]
28. c-Myb promotes growth and metastasis of colorectal cancer through c-fos-induced epithelial-mesenchymal transition.
Qu X; Yan X; Kong C; Zhu Y; Li H; Pan D; Zhang X; Liu Y; Yin F; Qin H
Cancer Sci; 2019 Oct; 110(10):3183-3196. PubMed ID: 31338937
[TBL] [Abstract][Full Text] [Related]
29. Orai1, a Direct Target of microRNA-519, Promotes Progression of Colorectal Cancer via Akt/GSK3β Signaling Pathway.
Deng W; Wang J; Zhang J; Cai J; Bai Z; Zhang Z
Dig Dis Sci; 2016 Jun; 61(6):1553-60. PubMed ID: 26792278
[TBL] [Abstract][Full Text] [Related]
30. MiR-452 promotes an aggressive colorectal cancer phenotype by regulating a Wnt/β-catenin positive feedback loop.
Li T; Jian X; He H; Lai Q; Li X; Deng D; Liu T; Zhu J; Jiao H; Ye Y; Wang S; Yang M; Zheng L; Zhou W; Ding Y
J Exp Clin Cancer Res; 2018 Sep; 37(1):238. PubMed ID: 30253791
[TBL] [Abstract][Full Text] [Related]
31. Effect of isorhamnetin on carbonic anhydrase IX expression and tumorigenesis of bladder cancer by activating PPARγ/PTEN/AKT pathway.
Zhang P; Sun Y; Shi L; Sun D; Wang L; Feng D; Ding C
Tissue Cell; 2023 Jun; 82():102048. PubMed ID: 36905861
[TBL] [Abstract][Full Text] [Related]
32. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer.
Lv Z; Wei J; You W; Wang R; Shang J; Xiong Y; Yang H; Yang X; Fu Z
J Transl Med; 2017 Dec; 15(1):257. PubMed ID: 29258530
[TBL] [Abstract][Full Text] [Related]
33. BRCA1-Interacting Protein OLA1 Requires Interaction with BARD1 to Regulate Centrosome Number.
Yoshino Y; Qi H; Fujita H; Shirota M; Abe S; Komiyama Y; Shindo K; Nakayama M; Matsuzawa A; Kobayashi A; Ogoh H; Watanabe T; Ishioka C; Chiba N
Mol Cancer Res; 2018 Oct; 16(10):1499-1511. PubMed ID: 29858377
[TBL] [Abstract][Full Text] [Related]
34. Normoxic accumulation of HIF1α is associated with glutaminolysis.
Kappler M; Pabst U; Rot S; Taubert H; Wichmann H; Schubert J; Bache M; Weinholdt C; Immel UD; Grosse I; Vordermark D; Eckert AW
Clin Oral Investig; 2017 Jan; 21(1):211-224. PubMed ID: 26955835
[TBL] [Abstract][Full Text] [Related]
35. PTBP3 contributes to colorectal cancer growth and metastasis via translational activation of HIF-1α.
Hou P; Chen F; Yong H; Lin T; Li J; Pan Y; Jiang T; Li M; Chen Y; Song J; Zheng J; Bai J
J Exp Clin Cancer Res; 2019 Jul; 38(1):301. PubMed ID: 31291975
[TBL] [Abstract][Full Text] [Related]
36. Blocking HIF signaling via novel inhibitors of CA9 and APE1/Ref-1 dramatically affects pancreatic cancer cell survival.
Logsdon DP; Shah F; Carta F; Supuran CT; Kamocka M; Jacobsen MH; Sandusky GE; Kelley MR; Fishel ML
Sci Rep; 2018 Sep; 8(1):13759. PubMed ID: 30214007
[TBL] [Abstract][Full Text] [Related]
37. Hypoxia inducible factor (HIf1alpha and HIF2alpha) and carbonic anhydrase 9 (CA9) expression and response of head-neck cancer to hypofractionated and accelerated radiotherapy.
Koukourakis MI; Giatromanolaki A; Danielidis V; Sivridis E
Int J Radiat Biol; 2008 Jan; 84(1):47-52. PubMed ID: 17852557
[TBL] [Abstract][Full Text] [Related]
38. Kinase GSK3β functions as a suppressor in colorectal carcinoma through the FTO-mediated MZF1/c-Myc axis.
Zhang Z; Gao Q; Wang S
J Cell Mol Med; 2021 Mar; 25(5):2655-2665. PubMed ID: 33533172
[TBL] [Abstract][Full Text] [Related]
39. Circ-SMARCA5 suppresses colorectal cancer progression via downregulating miR-39-3p and upregulating ARID4B.
Miao X; Xi Z; Zhang Y; Li Z; Huang L; Xin T; Shen R; Wang T
Dig Liver Dis; 2020 Dec; 52(12):1494-1502. PubMed ID: 32807692
[TBL] [Abstract][Full Text] [Related]
40. Crucial role of carbonic anhydrase IX in tumorigenicity of xenotransplanted adult T-cell leukemia-derived cells.
Nasu K; Yamaguchi K; Takanashi T; Tamai K; Sato I; Ine S; Sasaki O; Satoh K; Tanaka N; Tanaka Y; Fukushima T; Harigae H; Sugamura K
Cancer Sci; 2017 Mar; 108(3):435-443. PubMed ID: 28075522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
